target

INSITRO

bidder

Alexandria Venture Investments

£116m

38 dealmakers

target

Kinnate Biopharma

bidder

Nextech Invest

£74m

9 dealmakers

target

Velosbio

bidder

Cormorant Asset Management

£105m

16 dealmakers

target

Gemini Therapeutics

bidder

Fs Development Corp

£166m

45 dealmakers

target

Velosbio

bidder

Merck & Co

£2,116m

55 dealmakers

target

Nurix Therapeutics

bidder

Bain Capital Life Sciences

£95m

10 dealmakers

target

QUANTUM-SI

bidder

Highcape Capital Acquisition Corp

£1,052m

37 dealmakers

target

INSITRO

bidder

BLACKROCK

£287m

27 dealmakers

target

SOMALOGIC

bidder

Janus Henderson Investors

£891m

63 dealmakers

target

Genomics

bidder

Oxford Sciences Innovation

£21m

14 dealmakers

target

Inscripta

bidder

Foresite Capital Management

£108m

8 dealmakers

target

Crossover Health

bidder

Perceptive Advisors

£121m

18 dealmakers

target

Generation Bio

bidder

Wellington Management

£83m

12 dealmakers

target

Tango Therapeutics

bidder

Cormorant Asset Management

£257m

32 dealmakers

target

Eikon Therapeutics

bidder

The Column Group

£106m

6 dealmakers

target

HEALTHVERITY

bidder

Durable Capital Partners

£71m

8 dealmakers

target

Element Biosciences

bidder

Counterpoint Global - Morgan Stanley

£198m

12 dealmakers

target

Pardes Biosciences

bidder

Ecor1 Capital

£199m

37 dealmakers

target

Kriya Therapeutics

bidder

Woodline Partners

£72m

14 dealmakers

target

Mammoth Biosciences

bidder

Greenspring Associates

£108m

12 dealmakers

target

BIT.BIO

bidder

Charles River Laboratories International

£76m

8 dealmakers

target

Eikon Therapeutics

bidder

Harel Group

£382m

21 dealmakers

target

Maze Therapeutics

bidder

Driehaus Capital

£139m

12 dealmakers

target

DNANEXUS

bidder

Northpond Ventures

£151m

30 dealmakers

target

Kriya Therapeutics

bidder

Narya Capital

£220m

13 dealmakers

target

Immpact Bio

bidder

Foresite Capital Management

£81m

9 dealmakers

target

Odyssey Therapeutics

bidder

Svb Financial Group

£152m

14 dealmakers

target

ALUMIS

bidder

Cormorant Asset Management

£204m

5 dealmakers